The DOI matches its Crossref record.
Model‐based design and control of a small‐scale integrated continuous end‐to‐end mAb platform
Abstract
A continuous integrated bioprocess available from the earliest stages of process development allows for an easier, more efficient and faster development and characterization of an integrated process as well as production of small‐scale drug candidates. The process presented in this article is a proof‐of‐concept of a continuous end‐to‐end monoclonal antibody production platform at a very small scale based on a 200 ml alternating tangential flow filtration perfusion bioreactor, integrated with the purification process with a model‐based design and control. The downstream process, consisting of a periodic twin‐column protein A capture, a virus inactivation, a CEX column and an AEX column, was compactly implemented in a single chromatography system, with a purification time of less than 4 hr. Monoclonal antibodies were produced for 17 days in a high cell density perfusion culture of CHO cells with titers up to 1.0 mg/ml. A digital twin of the downstream process was created by modelling all the chromatography steps. These models were used for real‐time decision making by the implementation of control strategies to automatize and optimize the operation of the process. A consistent glycosylation pattern of the purified product was ensured by the steady state operation of the process. Regarding the removal of impurities, at least a 4‐log reduction in the HCP levels was achieved. The recovery yield was up to 60%, and a maximum productivity of 0.8 mg/ml/day of purified product was obtained.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unlike upstream processing, where several days are needed for cell culture and therapeutic protein production, the purification of the target product in downstream processing takes only a few hours [31].”
From Current PAT Landscape in the Downstream Processing of Biopharmaceuticals (2025) · cites this paper as [31]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 29
- Levine HL, 2017, The Development of Therapeutic Monoclonal Antibody Products
- 10.1016/j.jchromb.2006.07.037 · DOI · Paper page
- 10.1002/btm2.10061 · DOI · Paper page
- 10.1002/biot.201700721 · DOI · Paper page
- 10.1016/j.jbiotec.2016.12.005 · DOI
- 10.1002/bit.24584 · DOI · Paper page
- 10.1002/jps.24268 · DOI · Paper page
- 10.1016/j.biotechadv.2018.04.011 · DOI · Paper page
- 10.1002/btpr.2434 · DOI
- 10.1002/biot.201700691 · DOI
- 10.1016/j.jbiotec.2015.06.393 · DOI · Paper page
- 10.1002/biot.201800061 · DOI
- Jiang M, 2016, Integrated control of continuous (bio)pharmaceutical manufacturing, Am Pharm Rev, 19
- 10.1016/S0098-1354(00)00492-0 · doi:10.1016/s0098-1354(00)00492-0
- 10.1016/j.jbiotec.2019.12.017 · DOI · Paper page
- 10.1016/j.tibtech.2013.05.011 · DOI · Paper page
- 10.1016/j.jbiotec.2019.05.013 · DOI
- 10.1016/j.chroma.2009.09.017 · DOI
- 10.1016/j.chroma.2017.02.026 · DOI
- 10.1007/978-1-4471-6443-2_2 · doi:10.1007/978-1-4471-6443-2_2
- 10.1016/j.chroma.2018.03.060 · doi:10.1016/j.chroma.2018.03.060
- 10.1021/ie5023223 · doi:10.1021/ie5023223
- 10.1016/j.ijbiomac.2015.03.027 · DOI
- 10.1002/btpr.2871 · doi:10.1002/btpr.2871
- 10.1002/bit.21527 · DOI · Paper page
- 10.1002/btpr.2522 · DOI
- 10.1023/A:1025771421906 · DOI · Paper page
- 10.1002/bit.26069 · DOI
- 10.1080/10826068.2018.1446151 · DOI
Cited by
Bioprocess Control: Current Progress and Future Perspectives
Rathore, A. S., Mishra, S., Nikita, S., & Priyanka, P. (2021) · Life · doi:10.3390/life11060557 · Cited by 141
Challenges in the Development of Soft Sensors for Bioprocesses: A Critical Review
Brunner, V., Siegl, M., Geier, D., & Becker, T. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.722202 · Cited by 100
Current PAT Landscape in the Downstream Processing of Biopharmaceuticals
Sathiyapriyan, P., Mukherjee, S., Vogel, T., Essen, L., Boerema, D., Vey, M., & Kalina, U. (2025) · Analytical Science Advances · doi:10.1002/ansa.70013 · Cited by 45
Real‐Time Detection of mAb Aggregates in an Integrated Downstream Process
São Pedro, M. N., Isaksson, M., Gomis‐Fons, J., Eppink, M. H. M., Nilsson, B., & Ottens, M. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28466 · Cited by 16
Self-citationShi, C., Chen, X., Zhong, X., Yang, Y., Lin, D., & Chen, R. (2024) · Biotechnology and Bioengineering · doi:10.1002/bit.28660 · Cited by 13
Automated quality analysis in continuous downstream processes for small-scale applications
Tallvod, S., Espinoza, D., Gomis-Fons, J., Andersson, N., & Nilsson, B. (2023) · Journal of Chromatography A · doi:10.1016/j.chroma.2023.464085 · Cited by 11
Self-citation
Metadata
- Authors
- Gomis‐Fons, J., Schwarz, H., Zhang, L., Andersson, N., Nilsson, B., Castan, A., Solbrand, A., Stevenson, J., & Chotteau, V.
- Affiliations
- Department of Chemical Engineering Lund University Lund Sweden
- Department of Industrial Biotechnology School of Engineering Sciences in Chemistry, Biotechnology and Health, Royal Institute of Technology Stockholm Sweden
- GE Healthcare Life Sciences Uppsala Sweden
- Cobra Biologics, Analytical Development Södertälje Sweden
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2020-04-06
- Volume
- 36
- Issue
- 4
- ISSN
- 8756-7938
- 1520-6033
- Cited by
- 55
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.